Literature DB >> 24833202

The debate on warfarin use in dialysis patients with atrial fibrillation: more fuel for the fire.

Nisha Bansal1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24833202      PMCID： PMC4209313          DOI： 10.1053/j.ajkd.2014.04.017

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN： 0272-6386            Impact factor:   8.860


× No keyword cloud information.
  22 in total

1.  ACC/AHA/ESC Guidelines for the Management of Patients With Atrial Fibrillation: Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients With Atrial Fibrillation) Developed in Collaboration With the North American Society of Pacing and Electrophysiology.

Authors:  V Fuster; L E Rydén; R W Asinger; D S Cannom; H J Crijns; R L Frye; J L Halperin; G N Kay; W W Klein; S Lévy; R L McNamara; E N Prystowsky; L S Wann; D G Wyse; R J Gibbons; E M Antman; J S Alpert; D P Faxon; V Fuster; G Gregoratos; L F Hiratzka; A K Jacobs; R O Russell; S C Smith; W W Klein; A Alonso-Garcia; C Blomström-Lundqvist; G de Backer; M Flather; J Hradec; A Oto; A Parkhomenko; S Silber; A Torbicki
Journal:  Circulation       Date:  2001-10-23       Impact factor: 29.690

2.  Cardiovascular disease in chronic kidney disease. A clinical update from Kidney Disease: Improving Global Outcomes (KDIGO).

Authors:  Charles A Herzog; Richard W Asinger; Alan K Berger; David M Charytan; Javier Díez; Robert G Hart; Kai-Uwe Eckardt; Bertram L Kasiske; Peter A McCullough; Rod S Passman; Stephanie S DeLoach; Patrick H Pun; Eberhard Ritz
Journal:  Kidney Int       Date:  2011-07-13       Impact factor: 10.612

3.  Race, ethnicity, and state-by-state geographic variation in hemorrhagic stroke in dialysis patients.

Authors:  James B Wetmore; Milind A Phadnis; Jonathan D Mahnken; Edward F Ellerbeck; Sally K Rigler; Xinhua Zhou; Theresa I Shireman
Journal:  Clin J Am Soc Nephrol       Date:  2014-01-23       Impact factor: 8.237

4.  The increasing prevalence of atrial fibrillation among hemodialysis patients.

Authors:  Wolfgang C Winkelmayer; Amanda R Patrick; Jun Liu; M Alan Brookhart; Soko Setoguchi
Journal:  J Am Soc Nephrol       Date:  2011-01-13       Impact factor: 10.121

5.  The exclusion of patients with chronic kidney disease from clinical trials in coronary artery disease.

Authors:  D Charytan; R E Kuntz
Journal:  Kidney Int       Date:  2006-10-18       Impact factor: 10.612

6.  Apixaban in patients with atrial fibrillation.

Authors:  Stuart J Connolly; John Eikelboom; Campbell Joyner; Hans-Christoph Diener; Robert Hart; Sergey Golitsyn; Greg Flaker; Alvaro Avezum; Stefan H Hohnloser; Rafael Diaz; Mario Talajic; Jun Zhu; Prem Pais; Andrzej Budaj; Alexander Parkhomenko; Petr Jansky; Patrick Commerford; Ru San Tan; Kui-Hian Sim; Basil S Lewis; Walter Van Mieghem; Gregory Y H Lip; Jae Hyung Kim; Fernando Lanas-Zanetti; Antonio Gonzalez-Hermosillo; Antonio L Dans; Muhammad Munawar; Martin O'Donnell; John Lawrence; Gayle Lewis; Rizwan Afzal; Salim Yusuf
Journal:  N Engl J Med       Date:  2011-02-10       Impact factor: 91.245

7.  Atrial fibrillation in hemodialysis patients: clinical features and associations with anticoagulant therapy.

Authors:  Volker Wizemann; Lin Tong; Sudtida Satayathum; Alex Disney; Takashi Akiba; Rachel B Fissell; Peter G Kerr; Eric W Young; Bruce M Robinson
Journal:  Kidney Int       Date:  2010-01-06       Impact factor: 10.612

8.  Dabigatran versus warfarin in patients with atrial fibrillation.

Authors:  Stuart J Connolly; Michael D Ezekowitz; Salim Yusuf; John Eikelboom; Jonas Oldgren; Amit Parekh; Janice Pogue; Paul A Reilly; Ellison Themeles; Jeanne Varrone; Susan Wang; Marco Alings; Denis Xavier; Jun Zhu; Rafael Diaz; Basil S Lewis; Harald Darius; Hans-Christoph Diener; Campbell D Joyner; Lars Wallentin
Journal:  N Engl J Med       Date:  2009-08-30       Impact factor: 91.245

9.  Warfarin use associates with increased risk for stroke in hemodialysis patients with atrial fibrillation.

Authors:  Kevin E Chan; J Michael Lazarus; Ravi Thadhani; Raymond M Hakim
Journal:  J Am Soc Nephrol       Date:  2009-08-27       Impact factor: 10.121

10.  Atrial fibrillation and morbidity and mortality in a cohort of long-term hemodialysis patients.

Authors:  Simonetta Genovesi; Antonio Vincenti; Emanuela Rossi; Daniela Pogliani; Irene Acquistapace; Andrea Stella; Maria Grazia Valsecchi
Journal:  Am J Kidney Dis       Date:  2008-02       Impact factor: 8.860
View more
  1 in total

1.  Cause-Specific Mortality in Patients with Chronic Kidney Disease and Atrial Fibrillation.

Authors:  Medha Airy; Jesse D Schold; Stacey E Jolly; Susana Arrigain; Nisha Bansal; Wolfgang C Winkelmayer; Joseph V Nally; Sankar D Navaneethan
Journal:  Am J Nephrol       Date:  2018-07-26       Impact factor: 3.754
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.